These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Comparison of biological activity among nonfucosylated therapeutic IgG1 antibodies with three different N-linked Fc oligosaccharides: the high-mannose, hybrid, and complex types. Kanda Y, Yamada T, Mori K, Okazaki A, Inoue M, Kitajima-Miyama K, Kuni-Kamochi R, Nakano R, Yano K, Kakita S, Shitara K, Satoh M. Glycobiology; 2007 Jan; 17(1):104-18. PubMed ID: 17012310 [Abstract] [Full Text] [Related]
27. Phase IB clinical trial of the oligosaccharide processing inhibitor swainsonine in patients with advanced malignancies. Goss PE, Reid CL, Bailey D, Dennis JW. Clin Cancer Res; 1997 Jul; 3(7):1077-86. PubMed ID: 9815786 [Abstract] [Full Text] [Related]
28. Inhibition of N-linked oligosaccharide processing does not prevent the secretion of thyroglobulin. A study with swainsonine and deoxynojirimycin. Franc JL, Hovsepian S, Fayet G, Bouchilloux S. Eur J Biochem; 1986 May 15; 157(1):225-32. PubMed ID: 2940087 [Abstract] [Full Text] [Related]
32. Accumulation of pentamannose oligosaccharides in human mononuclear leukocytes by action of swainsonine, an inhibitor of glycoprotein processing. Kang MS, Bowlin TL, Vijay IK, Sunkara SP. Carbohydr Res; 1993 Oct 04; 248():327-37. PubMed ID: 8252542 [Abstract] [Full Text] [Related]
33. Swainsonine and castanospermine blockade of mannose glycoprotein uptake by macrophages. Apparent inhibition of receptor-mediated endocytosis by endogenous ligands. Chung KN, Shepherd VL, Stahl PD. J Biol Chem; 1984 Dec 10; 259(23):14637-41. PubMed ID: 6438101 [Abstract] [Full Text] [Related]
35. Swainsonine inhibits macrophage receptor-mediated uptake and degradation of a mannosyl-oligosaccharide. Arumugham RG, Tanzer ML. Biochem Biophys Res Commun; 1983 Nov 15; 116(3):922-30. PubMed ID: 6418175 [Abstract] [Full Text] [Related]
36. Abnormal glycosylation of human cellular fibronectin in the presence of swainsonine. Arumugham RG, Tanzer ML. J Biol Chem; 1983 Oct 10; 258(19):11883-9. PubMed ID: 6413506 [Abstract] [Full Text] [Related]
40. Modification of blood group A antigen expression in a pancreatic cancer cell line (PC-1) by inhibitors of N-glycan processing. Hirota M, Mogaki M, Pour PM, Chaney WG. J Cell Biochem; 1992 Sep 10; 50(1):13-20. PubMed ID: 1429870 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]